Health News (Reuters)

Indiana HIV outbreak among drug users may have been avoidable

(Reuters Health) - A years-long HIV outbreak among intravenous (IV) drug users in Indiana might have been avoided if the state's top medical and political leaders had acted sooner on early warnings that the virus was spreading, a recent study suggests.

U.S. FDA expands approval of Roche hemophilia drug

Roche on Thursday said U.S. regulators approved expanded use of its drug Hemlibra to include almost all patients with hemophilia A, as the Swiss drugmaker increases its focus on diseases beyond cancer to help replace revenue from older products that have lost patent protection.

Even light exercise might lessen severity of a future stroke

(Reuters Health) - People who regularly engage in light to moderate physical activity - like walking four hours a week or swimming two hours weekly - might have less severe strokes than individuals who aren't as active, a Swedish study suggests.

Non-white elders in U.S. less likely to use low-vision devices

(Reuters Health) - Older white people with very impaired eyesight are more likely to use low-vision devices that may improve independence, compared to elderly people in other racial and ethnic groups, a U.S. study suggests.

Blackstone buys Clarus to bulk up in life sciences

Blackstone Group LP said on Thursday it has agreed to acquire life sciences investment firm Clarus, in an effort by the world's largest alternative asset manager to scale up its investments in healthcare.

J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion

Arrowhead Pharmaceuticals Inc said on Thursday Johnson & Johnson would develop and market its gene-silencing Hepatitis B treatment and buy a minor stake in a deal that could be potentially worth more than $3.7 billion, sending its shares surging 20 percent.